BackgroundCheck.run
Search For

Jing Xie, 54Cleveland, OH

Jing Xie Phones & Addresses

Solon, OH   

4227 Hickory Ave, Baltimore, MD 21211    410-3665283   

2936 Saint Paul St, Baltimore, MD 21218    410-3665283   

35610 Spicebush Ln, Solon, OH 44139   

Work

Position: Clerical/White Collar

Education

Degree: High school graduate or higher

Mentions for Jing Xie

Career records & work history

Lawyers & Attorneys

Jing Xie Photo 1

Jing Xie - Lawyer

ISLN:
923929854
Admitted:
2014

License Records

Jing Xie

Licenses:
License #: 239024836 - Active
Issued Date: Sep 29, 2010
Expiration Date: Sep 30, 2018
Type: Registered Certified Public Accountant

Jing Xie resumes & CV records

Resumes

Jing Xie Photo 33

Jing Xie - Solon, OH

Work:
Cleveland Clinic May 2006 to 2000
Research Scientist
Education:
University of Akron - Akron, OH Aug 2012
Master in Statistics
Nanjing University 1999 to 2010
B.S. in Biochemistry and Molecular Biology
Peking University
M.S. in Biochemistry and Molecular Biology
Skills:
Regression Analysis, SAS, R, SQL, SPSS, JMP, Logistic Analysis, Categorical Analysis, etc.
Jing Xie Photo 34

Jing Xie - Cleveland, OH

Work:
New Balance China Dec 2010 to Apr 2011
Marketing Intern
Roundsmen Logistics Consulting & Software Co,ltd Jul 2009 to Aug 2009
Student Intern & Consulting Trainee
Education:
Weatherhead School of Management, Case Western Reserve University - Cleveland, OH 2011 to 2013
Master of Science in Operation Research & Supply Chain
Tongji University 2007 to 2011
Bachelor of Engineering in Logistic Engineering
Skills:
Computer Skills: MS Office, Storm(ERP), Arena(Computer Simulation), VB

Publications & IP owners

Us Patents

A H3T3A Mutant Protein Efficiently Reduces H3T3P And Causes Increased Cell Death Of Rapidly Dividing Cells

US Patent:
2018025, Sep 13, 2018
Filed:
Apr 6, 2016
Appl. No.:
15/565120
Inventors:
- Baltimore MD, US
Jing Xie - Ellicott City MD, US
International Classification:
A61K 38/17
A61K 45/06
C07K 14/47
A61P 35/00
Abstract:
The invention features compositions comprising an H3T3A mutant protein. Described herein are methods of inducing cell death in a rapidly dividing cell comprising contacting a rapidly dividing cell with an agent that reduces phosphorylation at threonine 3 of histone 3 (H3T3P), thereby inducing cell cycle arrest followed by cell death. In some cases, the rapidly dividing cell is a tumor cell, e.g., a cancer cell. The agent that reduces phosphorylation of H3T3P comprises an H3T3A mutant protein, e.g., a mutant transgenic protein. Described herein is a kit for arresting cell cycle comprising an agent that reduces phosphorylation H3T3P.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.